natgillin/translations-raw huggingface dataset:
What VISTIDE is and what it is used for 2.
Kaj je zdravilo VISTIDE in za kaj ga uporabljamo 2.
Before you use VISTIDE 3.
Kaj morate vedeti, preden boste uporabili zdravilo VISTIDE 3.
How to use VISTIDE 4.
Kako uporabljati zdravilo VISTIDE 4.
How to store VISTIDE 6.
Shranjevanje zdravila VISTIDE 6.
What VISTIDE is and what it is used for
Kaj je zdravilo VISTIDE in za kaj ga uporabljamo
VISTIDE is an antiviral medicine which blocks the replication of cytomegalovirus (CMV) by interfering with viral DNA production.
Zdravilo VISTIDE je protivirusno zdravilo, ki zavira razmnoževanje citomegalovirusov (CMV) tako, da ovira nastajanje virusne DNA.
VISTIDE is indicated in the treatment of CMV retinitis in patients with Acquired Immunodeficiency Syndrome (AIDS).
Zdravilo VISTIDE je indicirano za zdravljenje citomegalovirusnega retinitisa pri bolnikih s sindromom pridobljene imunske pomanjkljivosti (aidsom).
VISTIDE will not cure your CMV retinitis but may improve your condition by delaying progression of the disease.
Zdravilo VISTIDE citomegalovirusnega retinitisa ne ozdravi, lahko pa izboljša stanje, ker upočasni napredovanje bolezni.
VISTIDE is for intravenous (into a vein) infusion and is not for intraocular injection (direct injection into the eye).
Zdravilo VISTIDE je namenjeno za intravensko infundiranje (infuzijo v veno), ne za intraokularno injiciranje (injekcije neposredno v oko).
CMV attacks the retina of the eye and may cause loss of vision, and eventually lead to blindness.
CMV napade očesno mrežnico in lahko povzroči poslabšanje vida in končno tudi slepoto.
Patients with acquired immunodeficiency syndrome (AIDS) are at high risk of developing CMV retinitis or other forms of CMV disease such as colitis.
Bolnike s sindromom pridobljene imunske pomanjkljivosti (aidsom) zelo ogrožajo tako citomegalovirusni retinitis kot druge oblike bolezni zaradi CMV, npr. kolitis.
Before you use VISTIDE
Kaj morate vedeti, preden boste uporabili zdravilo VISTIDE
Do not use VISTIDE if you • Are hypersensitive (allergic) to cidofovir or any of the other ingredients of VISTIDE. • Have pre-existing kidney disease. • Or if you cannot take the medicine probenecid because of a serious allergy to probenecid or other sulfa-containing medications (e. g. sulfamethoxazole). • VISTIDE must not be administered by intraocular injection.
Ne uporabljajte zdravila VISTIDE • Če ste alergični na (preobčutljivi za) cidofovir ali katerokoli sestavino zdravila VISTIDE. • Če imate že od prej kakšno bolezen ledvic. • Ali če ne morete jemati zdravila probenecid, ker imate resno alergijo na probenecid ali druga zdravila, ki vsebujejo žveplo (npr. sulfametoksazol). • Zdravila VISTIDE se ne sme injicirati v oko.
20 Take special care with VISTIDE:
Bodite posebno pozorni pri uporabi zdravila VISTIDE:
Kidney damage is the major side effect of VISTIDE treatment.
Glavni neželeni učinek zdravljenja z zdravilom VISTIDE je okvara ledvic.
To minimise the potential for damage to the kidneys, you will receive intravenous fluids (normal saline) and probenecid tablets with each dose of VISTIDE.
Da bi možnost za okvaro ledvic čim bolj zmanjšali, boste z vsakim odmerkom zdravila VISTIDE dobili intravensko tekočino 20 (fiziološko raztopino) in tablete probenecida.
Your doctor will monitor your kidney function prior to each dose of VISTIDE.
Zdravnik bo pred vsakim odmerkom zdravila VISTIDE preveril delovanje vaših ledvic.
Your treatment with VISTIDE may be discontinued by your doctor if changes in kidney function occur.
Če se vam delovanje ledvic spremeni, lahko zdravnik zdravljenje z zdravilom VISTIDE prekine.
You may continue taking antiretrovirals (anti-HIV medications) and medication to prevent AIDS- related opportunistic infections.
Še naprej lahko jemljete protiretrovirusna zdravila (zdravila za zdravljenje virusa HIV) in zdravila za preprečevanje oportunističnih okužb, povezanih z aidsom.
However, because the side effects of VISTIDE include kidney damage, it will be necessary to stop taking all other medications that may also cause kidney damage.
Ker pa je med neželenimi učinki zdravila VISTIDE tudi okvara ledvic, boste morali opustiti vsa druga zdravila, ki bi prav tako lahko okvarila ledvice.
You should tell your doctor if you are receiving other medications which are known to potentially damage the kidney, such as tenofovir, aminoglycosides, amphotericin B, foscarnet, intravenous pentamidine, adefovir and vancomycin.
Svojemu zdravniku morate povedati, če dobivate tudi druga zdravila, za katera je znano, da lahko okvarijo ledvice, npr. tenofovir, aminoglikozide, amfotericin B, foskarnet, intravenski pentamidin, adefovir in vankomicin.
These medicines must be stopped AT LEAST 7 days before taking VISTIDE.
Zdravljenje s temi zdravili je treba opustiti VSAJ 7 dni pred začetkom zdravljenja z zdravilom VISTIDE.
Vistide is not used for the treatment of HIV infection.
Zdravilo VISTIDE se ne uporablja za zdravljenje okužbe z virusom HIV.
VISTIDE should be used with caution in diabetic patients due to the potential increased risk of developing ocular hypotony (low pressure in the eye).
Pri bolnikih z diabetesom je treba zdravilo VISTIDE uporabljati previdno, ker ga spremlja zvečano tveganje za očesno hipotonijo (nizek očesni tlak).
VISTIDE may cause transient side effects such as fatigue or weakness.
Zdravilo VISTIDE lahko povzroči prehodne neželene učinke, npr. utrujenost in šibkost.
If you drive or operate machinery, discuss this with your doctor to get their recommendation about discontinuing these activities based upon the condition of your disease and your tolerance of the medication.
Glede na stanje vaše bolezni in vaše prenašanje zdravila vam bo povedal, ali morate te dejavnosti prekiniti.
During treatment with VISTIDE you should receive regular follow-up ophthalmologic examinations for possible occurrence of eye irritation, inflammation or swelling.
Med zdravljenjem z zdravilom VISTIDE morate redno opravljati preglede oči zaradi morebitnega pojava draženja, vnetja ali otekanja oči.
Any pain, redness or itching of the eye or changes in your vision should be promptly reported to your doctor.
Če opazite kakršnokoli bolečino, pordelost ali srbenje oči ali spremembe vida, morate nemudoma obvestiti svojega zdravnika.
VISTIDE caused reduced testes weight and hypospermia (low sperm count) in animals.
V študijah na živalih je zdravilo VISTIDE zmanjšal težo mod in povzročil hipospermijo (majhno število semenčic).
Although not observed in human studies of VISTIDE, such changes may occur in humans and cause infertility.
Tega v študijah zdravilo VISTIDE pri ljudeh sicer niso opazili, vendar se takšne spremembe lahko pojavijo tudi pri človeku in povzročijo neplodnost.
Appropriate precautions should continue to be employed to prevent transmission of HIV.
Pomembno je, da nadaljujete z ustreznimi previdnostnimi ukrepi, da bi preprečili prenos HIV na druge.
You should not be given VISTIDE if you are pregnant.
Če ste noseči, ne smete dobiti zdravila VISTIDE.
If you become pregnant while taking this medication, you must inform your doctor immediately.
Če zanosite med uporabo tega zdravila, morate nemudoma obvestiti zdravnika.
VISTIDE has been shown to cause damage in unborn animals and should not be used during pregnancy unless the potential benefits justify the risks to the foetus.
Dokazano je, da zdravilo VISTIDE povzroča okvare pri nerojenih živalih, in se ga med nosečnostjo ne sme uporabljati, razen če možne koristi upravičujejo tveganja za plod.
Women of childbearing potential should use birth control methods during and for 1 month following treatment with VISTIDE.
Ženske v rodni dobi morajo med zdravljenjem z zdravilom VISTIDE in 1 mesec po takšnem zdravljenju uporabljati kontracepcijsko zaščito.
You should not be given VISTIDE if you are breast feeding.
Če dojite, ne smete dobiti zdravila VISTIDE.
It is not known whether VISTIDE is excreted in human milk.
Ni znano, ali se zdravilo VISTIDE izloča v materino mleko.
Because many medicines are excreted in human milk, nursing mothers should discontinue VISTIDE or stop nursing if they continue to receive VISTIDE.
Ker se v materino mleko izločajo številna zdravila, morajo doječe matere nehati dobivati zdravilo VISTIDE, ali pa morajo nehati dojiti, če še naprej dobivajo zdravilo VISTIDE.
In general, women infected with HIV should not breast-feed their infants in order to avoid transmission of HIV to their newborn infant through the milk.
Na splošno je priporočljivo, da ženske, okužene s HIV, ne dojijo, ker se virus na lahko prenese na dojenčka z materinim mlekom.
VISTIDE has not been studied in children.
Zdravilo VISTIDE pri otrocih ni raziskano.
Therefore, this medication should not be used in children.
Tega zdravila se torej ne sme uporabljati pri otrocih.
Using VISTIDE with food and drink:
Uporaba zdravila VISTIDE skupaj s hrano in pijačo:
Food should be taken prior to administration of VISTIDE.
Pred uporabo zdravila VISTIDE morate zaužiti hrano.
21 Important information about some of the ingredients of VISTIDE
21 Pomembne informacije o nekaterih sestavinah zdravila VISTIDE
VISTIDE contains sodium.
Zdravilo VISTIDE vsebuje natrij.
Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed as these may interact with cidofovir or probenecid.
Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta, saj lahko pride do medsebojnega delovanja s cidofovirom ali probenecidom.
Probenecid may interact with other medicines commonly used in the treatment of AIDS and AIDS- related illnesses, such as zidovudine (AZT).
Probenecid ima lahko medsebojne učinke z drugimi zdravili, ki se pogosto uporabljajo za zdravljenje aidsa in z aidsom povezanih bolezni, npr. z zidovudinom (AZT).
If you are taking zidovudine, you should discuss with your doctor the option to either temporarily discontinue zidovudine or decrease the dose of zidovudine by 50% on days when VISTIDE and probenecid are administered.
Če jemljete zidovudin, se morate z zdravnikom posvetovati, ali naj začasno prekinete uporabo zidovudina ali pa ob dneh, ko dobite zdravilo VISTIDE in probenecid, zmanjšate odmerek zidovudina za 50%.
The potential for interactions between VISTIDE and anti-HIV protease inhibitors has not been studied.
Možni medsebojni učinki med zdravilom VISTIDE in zaviralci proteaz proti HIV niso raziskani.
How to use VISTIDE
Kako uporabljati zdravilo VISTIDE
VISTIDE is administered by intravenous infusion and must not be administered by intraocular injection.
Zdravilo VISTIDE se uporablja v intravenski infuziji in se ga ne sme injicirati v oko.
VISTIDE must be administered by a health care professional.
Zdravilo VISTIDE mora dati zdravstveni delavec.
To minimise the potential for kidney damage, probenecid tablets and intravenous saline solution must be administered with each VISTIDE infusion.
Za zmanjšanje možnosti za okvaro ledvic je treba z vsako infuzijo zdravila VISTIDE uporabiti tablete probenecida in intravensko fiziološko raztopino.
The recommended dosage, frequency of use, or rate of infusion must not be exceeded.
Ne sme se preseči priporočenega odmerka, pogostnosti uporabe in hitrosti infundiranja.
Dosage in Adults
Odmerjanje pri odraslih
Induction Treatment.
Začetno zdravljenje.
The recommended dose of VISTIDE in patients with normal kidney function is 5 mg/ kg body weight (given as an intravenous infusion at a constant rate over 1 hour) administered once weekly for two consecutive weeks.
Priporočeni odmerek zdravila VISTIDE pri bolnikih z normalnim delovanjem ledvic je 5 mg/ kg telesne teže (v enourni intravenski infuziji s stalno hitrostjo) enkrat na teden, dva tedna zapored.
Maintenance Treatment.
Vzdrževalno zdravljenje.
Beginning two weeks after completion of induction treatment, the recommended maintenance dose of VISTIDE in patients with normal kidney function is 5 mg/ kg body weight (given as an intravenous infusion at a constant rate over 1 hr) administered once every two weeks.
Vzdrževalno zdravljenje se začne dva tedna po koncu začetnega; priporočeni vzdrževalni odmerek zdravila VISTIDE pri bolnikih z normalnim delovanjem ledvic je 5 mg/ kg telesne teže (v enourni intravenski infuziji s stalno hitrostjo) enkrat na dva tedna.
Dose Adjustment.
Prilagoditev odmerka.
If you have decreased kidney function, VISTIDE may not be appropriate therapy for you.
Če imate zmanjšano delovanje ledvic, zdravilo VISTIDE za vas morda ni primerno.
Samples of your urine and/ or blood will be obtained prior to each infusion of VISTIDE and used for testing kidney function.
Pred vsako infuzijo zdravila VISTIDE boste opravili pregled urina in/ ali krvi za oceno delovanja ledvic.
For patients with evidence of decreased kidney function, your VISTIDE dose may be interrupted or discontinued depending on your individual case.
Če se izkaže, da je delovanje ledvic zmanjšano, lahko zdravnik uporabo zdravila VISTIDE prekine ali konča, odvisno od vašega individualnega stanja.
If you have accidentally been administered a dose of VISTIDE greater than prescribed for you, tell your doctor immediately.
Če ste pomotoma prejeli večji odmerek zdravila VISTIDE, kot vam je bil predpisan, to nemudoma povejte zdravniku.
Can VISTIDE be mixed with other medications prior to use?
Se lahko zdravilo VISTIDE pred uporabo meša z drugimi zdravili?
No other medications or supplements should be added to the VISTIDE infusion bag.
V infuzijsko vrečko z zdravilom VISTIDE se ne sme dajati drugih zdravil ali dodatkov.
How will VISTIDE be prepared and given?
Priprava in dajanje zdravila VISTIDE
VISTIDE vials should be inspected visually prior to use.
Viale zdravila VISTIDE je treba pred uporabo pregledati.
If visible particles or discoloration are observed, the vial should not be used.
Če so opazni vidni delci ali obarvanje, se takšne viale ne sme uporabiti.
The health care professional (e. g., physician/ nurse) will transfer the appropriate dose of VISTIDE from the vial to an infusion bag containing 100 ml 0.9% (normal) saline solution.
Zdravstveni delavec (npr. zdravnik ali medicinska sestra) bo ustrezen odmerek zdravila VISTIDE prenesel iz viale v infuzijsko vrečko, v kateri je 100 ml 0, 9% (normalne) fiziološke raztopine.
The entire volume of the bag will be infused intravenously into you at a constant rate over a period of 1 hour by use of a standard infusion pump.
Celotno vsebino vrečke vam bodo s standardno infuzijsko črpalko v teku ene ure s stalno hitrostjo infundirali v veno.
22 The chemical stability of VISTIDE mixed in saline solution has been demonstrated in glass bottles, in infusion bags composed of either polyvinyl chloride (PVC) composition or ethylene/ propylene copolymer, and in PVC based vented I. V. administration sets.
22 Kemična stabilnost zdravila VISTIDE, zmešanega s fiziološko raztopino, je dokazana v steklenih steklenicah, infuzijskih vrečkah iz polivinilklorida (PVC) ali etilen/ propilenskega kopolimera ter v ventiliranih kompletih za intravensko apliciranje, izdelanih na podlagi PVC.
Compatibility of VISTIDE with Ringer’ s Solution, Lactated Ringer’ s Solution or bacteriostatic infusion fluids has not been evaluated.
Združljivost zdravila VISTIDE z Ringerjevo raztopino, Ringerjevo laktatno raztopino in bakteriostatskimi infuzijskimi tekočinami ni raziskana.
Chemical and physical in-use stability has been demonstrated for up to 24 hours at 2 – 8 ºC when dilution is performed under controlled and validated aseptic conditions.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 24 ur pri temperaturi od 2- 8 °C, če je bilo razredčenje izvedeno pod kontroliranimi in validiranimi aseptičnimi pogoji.
Adequate precautions including the use of appropriate safety equipment are recommended for the preparation, administration and disposal of VISTIDE.
Pri pripravi, uporabi in odstranjevanju zdravila VISTIDE je treba upoštevati ustrezne previdnostne ukrepe, vključno z uporabo primerne varnostne opreme.
The preparation of VISTIDE diluted solution should be done in a laminar flow biological safety cabinet.
Raztopino zdravila VISTIDE je treba pripraviti v biološkem varnostnem sistemu z laminarnim pretokom.
Why is the medication probenecid given with VISTIDE?
Zakaj se zdravilo VISTIDE uporablja s probenecidom?
Probenecid tablets are given to minimise the potential for kidney damage.
Tablete probenecida se uporabljajo, da bi zmanjšali možnost za okvaro ledvic.
You must receive a course of probenecid tablets administered orally with each VISTIDE dose.
Ob vsakem odmerku zdravila VISTIDE morate zaužiti cikel tablet probenecida.
Two grams must be administered 3 hours prior to the VISTIDE dose and one gram administered at 2 hours and again at 8 hours after completion of the 1 hour VISTIDE infusion (for a total of 4 grams).
Dva grama morate dobiti 3 ure pred odmerkom zdravila VISTIDE, en gram 2 uri in še en gram 8 ur po koncu enourne infuzije zdravila VISTIDE (skupaj 4 grame).
Probenecid is only taken on the same day that VISTIDE is administered.
Probenecid dobite samo na dan uporabe zdravila VISTIDE.
See section 6 for further information on obtaining probenecid.
Za informacije o tem, kako si preskrbeti probenecid, glejte poglavje 6.
Why is normal saline solution given with VISTIDE?
Zakaj se zdravilo VISTIDE uporablja s fiziološko raztopino?
Normal saline is given to minimise the potential for kidney damage.
Fiziološka raztopina se uporablja, da bi zmanjšali možnost za okvaro ledvic.
You should receive a total of one litre of 0.9% (normal) saline solution intravenously with each infusion of VISTIDE.
Z vsako infuzijo zdravila VISTIDE morate dobiti skupno en liter 0, 9% (normalne) fiziološke raztopine intravensko.
The saline solution should be infused over a 1 hour period immediately before the VISTIDE infusion.
Fiziološko raztopino vam morajo infundirati v enournem obdobju tik pred infuzijo zdravila VISTIDE.
If administered, the second litre of saline should be initiated either at the start of the VISTIDE infusion or immediately afterwards, and infused over a 1 to 3 hour period.
V tem primeru je treba drugi liter fiziološke raztopine nastaviti bodisi na začetku infundiranja zdravila VISTIDE ali takoj po njegovem koncu in mora teči v obdobju od 1 do 3 ur.
Like all medicines, VISTIDE can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi zdravilo VISTIDE neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
The side effects in this section are given with an estimation of the frequency with which they may occur.
Tukaj opisani neželeni učinki so podani z oceno pogostnosti, s katero se lahko pojavijo.
For this purpose, the following frequency categories and denominations have been used:
Uporabljena je naslednja razvrstitev in poimenovanje pogostnosti:
Very common: side effects which may occur in more than 1 in 10 patients.
Zelo pogosto: neželeni učinki, ki se lahko pojavijo pri več kot 1 od 10 bolnikov.
Common: side effects which may occur in 1 to 10 out of 100 patients.
Pogosto: neželeni učinki, ki se lahko pojavijo pri 1 do 10 od 100 bolnikov.
Uncommon: side effects which may occur in 1 to 10 out of 1000 patients.
Občasno: neželeni učinki, ki se lahko pojavijo pri 1 do 10 od 1. 000 bolnikov.
23 Rare: side effects which may occur in 1 to 10 out of 10 000 patients.
23 Redko: neželeni učinki, ki se lahko pojavijo pri 1 do 10 od 10. 000 bolnikov.
Very rare: side effects which may occur in less than 1 out of 10 000 patients.
Zelo redko: neželeni učinki, ki se lahko pojavijo pri manj kot 1 od 10. 000 bolnikov.
The most common side effect observed with VISTIDE has been damage to the kidneys.
Najpogostejši neželeni učinek, opažen med uporabo zdravila VISTIDE, je okvara ledvic.
Very common side effects are: low white blood cell counts, headache, nausea, vomiting, protein in the urine, increase in blood creatinine (a measure of kidney function), hair loss, rash, weakness/ fatigue and fever.
Zelo pogosti neželeni učinki so: znižano število belih krvnih celic, glavobol, slabost s siljenjem na bruhanje, bruhanje, beljakovine v urinu, zvišanje ravni kreatinina v serumu (merilo delovanja ledvic), izpadanje las, izpuščaj, šibkost/ utrujenost in zvišana telesna temperatura.
Common side effects are: inflammation of the eye, reduced pressure in the eyes, difficult or laboured breathing, shortness of breath and chills.
Pogosti stranski učinki so: vnetje oči, znižan očesni tlak, oteženo ali naporno dihanje, kratka sapa in mrzlica.
Additional reactions reported from post marketing experience include kidney failure, inflammation of the pancreas and hearing impairment.
Dodatni neželeni učinki, o katerih so poročali po prihodu zdravila na trg, vključujejo odpoved ledvic, vnetje trebušne slinavke in motnje sluha.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist immediately.
Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
These side effects usually disappear when treatment with VISTIDE is stopped.
Ti neželeni učinki ponavadi izginejo, ko se zdravljenje z zdravilom VISTIDE konča.
What are the possible side effects of taking probenecid?
Kateri so možni neželeni učinki jemanja probenecida?
Very common side effects possibly related to probenecid are nausea, vomiting, rash and fever.
Zelo pogosti neželeni učinki, ki so morda povezani s probenecidom, so slabost s siljenjem na bruhanje, bruhanje, izpuščaj in vročina.
Common side effects possibly related to probenecid include headache, weakness/ fatigue, chills and allergic reactions.
Pogosti neželeni učinki, ki so morda povezani s probenecidom, vključujejo glavobol, šibkost/ utrujenost, mrzlico in alergijske reakcije.
To decrease the potential for nausea and/ or vomiting associated with taking probenecid, you should eat food prior to each dose of probenecid.
Za zmanjšanje možnosti za slabost in/ ali bruhanje, ki sta povezana z jemanjem probenecida, morate pred vsakim odmerkom probenecida zaužiti hrano.
Your Doctor might instruct you to take other medications such as antiemetics, antihistamines and/ or paracetamol to decrease the side effects of probenecid.
Vaš zdravnik vam lahko naroči, da za ublažitev neželenih učinkov probenecida uporabite še druga zdravila, npr. antiemetike, antihistaminike in/ ali paracetamol.
Probenecid may also cause other side effects including loss of appetite, sore gums, flushing, hair loss, dizziness, reduced red blood cell count and increased frequency to urinate.
Probenecid lahko povzroči tudi druge neželene učinke, kot so izguba apetita, boleče dlesni, zardevanje, izpadanje las, omotica, znižano število rdečih krvnih celic in večja pogostost uriniranja.
Therefore before being given probenecid your doctor should consult the current prescribing information for further information regarding the safety of that product.
Preden vam predpiše probenecid, mora vaš zdravnik za dodatne podatke o varnosti preveriti veljavne informacije o predpisovanju za to zdravilo.
How to store VISTIDE
Shranjevanje zdravila VISTIDE
What VISTIDE contains
Kaj vsebuje zdravilo VISTIDE
The active substance of VISTIDE 75 mg/ ml is cidofovir.
Zdravilna učinkovina v zdravilu VISTIDE 75 mg/ ml je cidofovir.
Each vial contains 375 mg/ 5ml cidofovir anhydrous
Ena viala vsebuje 375 mg/ 5 ml brezvodnega cidofovira.
The other ingredients are Sodium Hydroxide Hydrochloric Acid Water for injection
Pomožne snovi so: natrijev hidroksid klorovodikova kislina voda za injekcije
What VISTIDE looks like and contents of the pack
Izgled zdravila VISTIDE in vsebina pakiranja
VISTIDE is supplied as a sterile concentrate for solution for infusion in clear, glass vials containing 375 mg of the active ingredient, anhydrous cidofovir, in 5 ml formulated in Water for Injection at a concentration of 75 mg/ ml.
Zdravilo VISTIDE je na voljo kot sterilen koncentrat za raztopino za infundiranje v prozornih steklenih vialah, ki vsebujejo 375 mg zdravilne učinkovine, brezvodnega cidofovira, v 5 ml vode za injekcije, tako da je koncentracija 75 mg/ ml.